AU9487698A - Methods and compositions for treating cardiac and renal disorders with atrial natriuretic peptide and tissue kallikrein gene therapy - Google Patents

Methods and compositions for treating cardiac and renal disorders with atrial natriuretic peptide and tissue kallikrein gene therapy

Info

Publication number
AU9487698A
AU9487698A AU94876/98A AU9487698A AU9487698A AU 9487698 A AU9487698 A AU 9487698A AU 94876/98 A AU94876/98 A AU 94876/98A AU 9487698 A AU9487698 A AU 9487698A AU 9487698 A AU9487698 A AU 9487698A
Authority
AU
Australia
Prior art keywords
compositions
methods
gene therapy
natriuretic peptide
atrial natriuretic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU94876/98A
Inventor
Julie Chao
Lee Chao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MUSC Foundation for Research Development
Original Assignee
MUSIC FOUNDATION FOR RESEARCH
MUSC Foundation for Research Development
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MUSIC FOUNDATION FOR RESEARCH, MUSC Foundation for Research Development filed Critical MUSIC FOUNDATION FOR RESEARCH
Publication of AU9487698A publication Critical patent/AU9487698A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4853—Kallikrein (3.4.21.34 or 3.4.21.35)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU94876/98A 1997-09-11 1998-09-11 Methods and compositions for treating cardiac and renal disorders with atrial natriuretic peptide and tissue kallikrein gene therapy Abandoned AU9487698A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5851197P 1997-09-11 1997-09-11
US60058511 1997-09-11
PCT/US1998/019267 WO1999012576A2 (en) 1997-09-11 1998-09-11 Methods and compositions for treating cardiac and renal disorders with atrial natriuretic peptide and tissue kallikrein gene therapy

Publications (1)

Publication Number Publication Date
AU9487698A true AU9487698A (en) 1999-03-29

Family

ID=22017263

Family Applications (1)

Application Number Title Priority Date Filing Date
AU94876/98A Abandoned AU9487698A (en) 1997-09-11 1998-09-11 Methods and compositions for treating cardiac and renal disorders with atrial natriuretic peptide and tissue kallikrein gene therapy

Country Status (2)

Country Link
AU (1) AU9487698A (en)
WO (1) WO1999012576A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000071576A2 (en) * 1999-05-24 2000-11-30 Mayo Foundation For Medical Education And Research Adenovirus vectors encoding brain natriuretic peptide
US6407211B1 (en) 1999-12-17 2002-06-18 Mayo Foundation For Medical Education And Research Chimeric natriuretic peptides
US8580746B2 (en) 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
BRPI0709427A2 (en) 2006-03-30 2011-07-12 Palatin Technologies Inc "Cyclic construct, pharmaceutical composition and use of a compound
JP2009532385A (en) 2006-03-30 2009-09-10 パラティン・テクノロジーズ・インコーポレーテッド Linear natriuretic peptide construct
WO2010078325A2 (en) * 2008-12-29 2010-07-08 Mayo Foundation For Medical Education And Research Natriuretic polypeptides for reducing or preventing restenosis
CN103906761B (en) 2011-08-30 2016-12-21 梅约医学教育与研究基金会 Profit sodium polypeptide
WO2013103896A1 (en) 2012-01-06 2013-07-11 Mayo Foundation For Medical Education And Research Treating cardiovascular or renal diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5668618A (en) * 1979-11-06 1981-06-09 Green Cross Corp:The Remedy for disease related to disorder of circulatory organ consisting essentially of kallikrein of human urine

Also Published As

Publication number Publication date
WO1999012576A2 (en) 1999-03-18
WO1999012576A3 (en) 1999-06-03

Similar Documents

Publication Publication Date Title
AU1520699A (en) Methods for treatment of disorders of cardiac contractility
AU4787697A (en) Therapeutic gene
AU9203998A (en) Cardiac pacing with multiple pacing therapy features
AU6530600A (en) Use of neurotoxin for treating cardiac muscle disorders
AU8659598A (en) Iontophoretic delivery of an agent into cardiac tissue
AU1102399A (en) Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2
AU6506698A (en) Tissue implant
AU5963900A (en) Muteins of bilin-binding protein
AU6558098A (en) Intracardiac defibrillation system
AU3021795A (en) Atrial defibrillator having patient activated modality
AU3111700A (en) Methods and compositions for treating inflammatory diseases utilizing inhibitorsof tumor necrosis factor activity
AU7705098A (en) Human tumor necrosis factor receptor-like protein 8
AUPO833497A0 (en) Improved heart pacemaker
AU9487698A (en) Methods and compositions for treating cardiac and renal disorders with atrial natriuretic peptide and tissue kallikrein gene therapy
AU2969597A (en) Treatment of vascular lesions
AU5780398A (en) Pharmaceutical composition for treatment of heart disease based on cardiac hypertrophy
AU5020196A (en) Human fas gene promoter region
AU5262200A (en) Arrangement in ventilatory treatment of the lungs
AU4823999A (en) Methods and compositions for treating diseases mediated by transglutaminase activity
AU6254799A (en) Anti-ige gene therapy
AU9017598A (en) Human frezzled-like protein
AU6883398A (en) Methods of treating bone loss
AU7609298A (en) Treatment of heart failure with growth hormone
AU3983899A (en) Human promonocyte associated protein: prmnc
AU2171695A (en) Agents for treating metabolic bone diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase